Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer

Author： Saw Constance Lay Lay   Kong Ah-Ng Tony  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.3, 2011-03, pp. : 281-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1015-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer

By Ohmori Hitoshi   Luo Yi   Kuniyasu Hiroki  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 183-193

Informa Healthcare

Access to resources Recommend Favorite

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer

By  

Current Drug Targets, Vol. 18, Iss. 2, 2016-12 ,pp. : 232-253

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) against Oxidative Stress in Cardiovascular Related Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1465-1470

Bentham Science Publishers

Access to resources Recommend Favorite

cIAP2 as a therapeutic target in colorectal cancer and other malignancies

By Miura Koh   Karasawa Hideaki   Sasaki Iwao  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1333-1345

Informa Healthcare

Access to resources Recommend Favorite